Search results
-
Blog
Case Study: Innovative Nanosuspension Approach to Maximize API Potency in Preclinical Formulation Development
Altasciences helped a client develop a robust preclinical formulation prototype at the maximum potency for their API BSC Class II compound.
-
Blog
Five Promising Treatment Areas in Early-Phase Drug Development in 2024
Explore emerging areas of drugs from psychedelics and gene therapy, oligonucleotides to GLP-1RA for metabolic disorders.